Oral VP-16-213 in advanced bronchogenic carcinoma.
AUTOR(ES)
Cantwell, B
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=471719Documentos Relacionados
- Oral VP-16-213 in advanced bronchogenic carcinoma and toxic effects when combined with methotrexate.
- Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death.
- Incidence of paramalignant disorders in bronchogenic carcinoma.
- Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma.
- Bronchoscopic cryotherapy for advanced bronchial carcinoma.